Encompass Health (EHC)
(Delayed Data from NYSE)
$82.47 USD
-0.26 (-0.31%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $82.47 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth C Momentum A VGM
Cash flow Statements
Fiscal Year End for Encompass Health Corporation falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 463.00 | 365.90 | 517.20 | 368.80 | 445.80 |
Depreciation/Amortization & Depletion | 283.40 | 253.30 | 264.40 | 250.20 | 223.20 |
Net Change from Assets/Liabilities | 50.30 | -30.40 | -118.00 | -7.30 | -180.10 |
Net Cash from Discontinued Operations | -4.00 | 37.10 | -0.10 | -0.20 | -3.80 |
Other Operating Activities | 58.10 | 79.90 | 52.30 | 93.20 | 150.20 |
Net Cash From Operating Activities | 850.80 | 705.80 | 715.80 | 704.70 | 635.30 |
Property & Equipment | -583.10 | -574.00 | -544.70 | -404.70 | -385.40 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | -118.60 | -1.10 | -231.50 |
Investments | -23.00 | -35.20 | -9.00 | -8.70 | -32.90 |
Other Investing Activities | 3.30 | -17.80 | 6.00 | 7.00 | -7.60 |
Net Cash from Investing Activities | -602.80 | -627.00 | -666.30 | -407.50 | -657.40 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 0.00 | 0.00 | -6.10 | -45.90 |
Issuance (Repayment) of Debt | -83.30 | -498.20 | -66.30 | 206.70 | 476.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | -60.40 | -99.00 | -112.40 | -111.90 | -108.70 |
Other Financing Activities | -53.50 | 451.50 | -61.40 | -234.60 | -273.20 |
Net Cash from Financing Activities | -197.20 | -145.70 | -240.10 | -145.90 | 48.20 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 50.80 | -66.90 | -190.60 | 151.30 | 26.10 |
Cash at Beginning of Period | 53.40 | 120.30 | 310.90 | 159.60 | 133.50 |
Cash at End of Period | 104.20 | 53.40 | 120.30 | 310.90 | 159.60 |
Diluted Net EPS | 3.47 | 2.70 | 4.11 | 2.85 | 3.61 |
Fiscal Year End for Encompass Health Corporation falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | 463.00 | 343.90 | 230.50 | 113.30 |
Depreciation/Amortization & Depletion | NA | 283.40 | 203.80 | 136.50 | 63.90 |
Net Change from Assets/Liabilities | NA | 50.30 | 58.90 | 41.40 | 37.90 |
Net Cash from Discontinued Operations | NA | -4.00 | -1.10 | -0.70 | -0.30 |
Other Operating Activities | NA | 58.10 | 44.30 | 26.90 | 13.10 |
Net Cash From Operating Activities | NA | 850.80 | 649.80 | 434.60 | 227.90 |
Property & Equipment | NA | -583.10 | -360.50 | -213.80 | -96.60 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | -23.00 | -21.10 | 0.00 | 0.00 |
Other Investing Activities | NA | 3.30 | -13.10 | -18.70 | -7.40 |
Net Cash from Investing Activities | NA | -602.80 | -394.70 | -232.50 | -104.00 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | NA | -83.30 | -77.20 | -50.20 | -15.60 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | -60.40 | -45.50 | -30.50 | -15.60 |
Other Financing Activities | NA | -53.50 | -44.60 | -20.80 | -26.80 |
Net Cash from Financing Activities | NA | -197.20 | -167.30 | -101.50 | -58.00 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | 50.80 | 87.80 | 100.60 | 65.90 |
Cash at Beginning of Period | NA | 53.40 | 53.40 | 53.40 | 53.40 |
Cash at End of Period | NA | 104.20 | 141.20 | 154.00 | 119.30 |
Diluted Net EPS | NA | 0.86 | 0.84 | 0.90 | 0.87 |